Atherosclerosis
Volume 204, Issue 1 , Pages 40-46, May 2009

The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells

Vascular Immunology Laboratory, CHUM Research Centre, Notre-Dame Hospital, JA de Seve Pavilion Y-4625, 1560 Sherbrooke Street East Montreal, Department of Medicine, University of Montreal, Quebec, Canada H2L 4M1

Received 18 March 2008; received in revised form 24 July 2008; accepted 6 August 2008. published online 18 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0021-9150(08)00552-2

doi:10.1016/j.atherosclerosis.2008.08.008

Atherosclerosis
Volume 204, Issue 1 , Pages 40-46, May 2009

Article Tools

* Image Usage & Resolution